Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
2020
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2
2021
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
2023 StandoutNobel
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Kinetics and isotype assessment of antibodies targeting the spike protein receptor‐binding domain of severe acute respiratory syndrome‐coronavirus‐2 in COVID‐19 patients as a function of age, biological sex and disease severity
2020
A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria
2023 StandoutNobel
A combined fine needle aspiration and spectral flow cytometry approach to assess human germinal center responses to SARS-CoV-2 vaccination
2022
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
2021
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
2021 StandoutNobel
Modeling serological testing to inform relaxation of social distancing for COVID-19 control
2021
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis
2003
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
2021 Nature
Coronavirus biology and replication: implications for SARS-CoV-2
2020 Standout
Mechanisms of SARS-CoV-2 entry into cells
2021 Standout
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
2021
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
2021
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Specific mRNA lipid nanoparticles and acquired resistance to ticks
2023 StandoutNobel
Optimal adaptive testing for epidemic control: Combining molecular and serology tests
2023 StandoutNobel
Transmissibility and transmission of respiratory viruses
2021
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
2022 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Multiple sclerosis
2008 Standout
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
2021
Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies
2021 StandoutNobel
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
2022 StandoutNobel
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
A global database of COVID-19 vaccinations
2021 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
SARS-CoV-2 variants, spike mutations and immune escape
2021 Standout
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
2020
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
2022
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
SARS-CoV-2 vaccines in development
2020 StandoutNature
Adaptive immunity to SARS-CoV-2 and COVID-19
2021
Looking beyond COVID-19 vaccine phase 3 trials
2021
IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody
2019
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
2021
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
2020
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
2022
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
2021
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
2021 Standout
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury
2023 StandoutNobel
CD4+ follicular regulatory T cells optimize the influenza virus–specific B cell response
2020
Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity
2005
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent
2021 StandoutNobel
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
2020
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
2022
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
2002
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Challenges of Making Effective Influenza Vaccines
2020
Airborne transmission of respiratory viruses
2021 StandoutScience
Exploring the Interrelationship between COVID-19 Phobia, Work–Family Conflict, Family–Work Conflict, and Life Satisfaction among School Administrators for Advancing Sustainable Management
2021 Standout
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002
Works of Daniel Stadlbauer being referenced
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
2020 Science
Immunological imprinting of the antibody response in COVID-19 patients
2021
Novel correlates of protection against pandemic H1N1 influenza A virus infection
2019
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
2019
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
2019
SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
2020
Broadly protective human antibodies that target the active site of influenza virus neuraminidase
2019 Science
A comparative study of the relative bioavailability of different interferon beta preparations
2000
Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
2017
Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice
2019
Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs
2019
Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults
2019